Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Hepatology

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/HEP.510290355PMID 10051469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.

  2008cited by this paper
• Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.

  1998cited by this paper
• Role of NF-κB in the Antiproliferative Effect of Endothelin-1 and Tumor Necrosis Factor-α in Human Hepatic Stellate Cells

  1998cited by this paper
• Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells.

  1997cited by this paper
• Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.

  1997cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• Tumorigenic Transformation of Immortalized ECV Endothelial Cells by Cyclooxygenase-1 Overexpression*

  1997cited by this paper
• Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat.

  1997cited by this paper
• Enhancement of prostaglandin E2 production by epidermal growth factor requires the coordinate activation of cytosolic phospholipase A2 and cyclooxygenase 2 in human squamous carcinoma A431 cells.

  1997cited by this paper
• Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type

  1997cited by this paper
• Interferon g Induces Prostaglandin G/H Synthase-2 through an Autocrine Loop via the Epidermal Growth Factor Receptor in Human Bronchial Epithelial Cells

  1997cited by this paper
• Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells.

  1997cited by this paper
• CELLULAR AND MOLECULAR BIOLOGY OF THE INFLAMED LIVER

  1997cited by this paper
• Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.

  1996cited by this paper
• Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation.

  1996cited by this paper
• Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines.

  1996cited by this paper
• Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

  1996cited by this paper
• Differential Growth Inhibition by the Aspirin Metabolite Salicylate in Human Colorectal Tumor Cell Lines: Enhanced Apoptosis in Carcinoma and in Vitro-transformed Adenoma Relative to Adenoma Cell Lines

  1996cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

  1995cited by this paper
• Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

  1995cited by this paper
• Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

  1995cited by this paper
• Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide.

  1995cited by this paper
• Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B

  1995cited by this paper
• Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II

  1995cited by this paper
• Eicosanoids and the gastrointestinal tract.

  1995cited by this paper
• Differentiation and tumor progression.

  1995cited by this paper
• Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

  1995cited by this paper
• Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor.

  1995cited by this paper
• Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

  1995cited by this paper
• Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.

  1994cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation.

  1994cited by this paper
• Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma.

  1993cited by this paper
• Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells

  1993cited by this paper
• Human cyclooxygenase-2 cDNA.

  1992cited by this paper
• Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study.

  1992cited by this paper
• The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound‐guided fine‐needle biopsy with those of autopsy

  1992cited by this paper
• Transforming growth factor‐alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver

  1992cited by this paper
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

  1991cited by this paper
• Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.

  1991cited by this paper
• Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma.

  1991cited by this paper
• TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

  1991cited by this paper
• Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment.

  1990cited by this paper
• TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas.

  1990cited by this paper
• Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts.

  1990cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper
• Chemoprevention of Colon Carcinogenesis by Sulindac , a Nonsteroidal Anti-inflammatory Agent 1

  year unknowncited by this paper

• A novel near-infrared COX-2 targeting probe for tumor and metastatic lymph node monitoring.

  2026cites this paper
• Protein kinase a suppresses antiproliferative effect of interferon-α in hepatocellular carcinoma by activation of protein tyrosine phosphatase SHP2

  2025cites this paper
• Genetic Analyses of Primary Liver Cancer Cell Lines: Correspondence With Morphological Features of Original Tumors

  2024cites this paper
• Codelivery of TGFβ and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint Inhibitors

  2024cites this paper
• A novel black poplar propolis extract with promising health-promoting properties: focus on its chemical composition, antioxidant, anti-inflammatory, and anti-genotoxic activities.

  2024cites this paper
• Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4

  2024cites this paper
• A study on construction of a prognosis model for liver cancer based on analgesic targets and screening therapeutic drugs

  2024cites this paper
• Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review

  2024cites this paper
• Cooperation between Prostaglandin E2 and Epidermal Growth Factor Receptor in Cancer Progression: A Dual Target for Cancer Therapy

  2023cites this paper
• Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer

  2023cites this paper
• Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development

  2023influential citation
• Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors.

  2023cites this paper
• Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia

  2023cites this paper
• Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis

  2022cites this paper
• The altered lipidome of hepatocellular carcinoma.

  2022cites this paper
• Evaluation of the hepatoprotective and antioxidant effects of Tegillarca granosa flesh body extract against potassium bromide toxicity via targeting the histomorphometry, chromosomal and expressions of TGF-β1, VEGF and COX-2 genes in rats

  2022cites this paper
• The correlation between P53 and COX-2 expression and the pathological alteration in hepatocellular carcinoma

  2022cites this paper
• Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis

  2022cites this paper
• Role of Nitric Oxide in Gene Expression Regulation during Cancer: Epigenetic Modifications and Non-Coding RNAs

  2021cites this paper
• POSSIBLE TREATMENT APPROACHES FOR HEPATOCELLULAR CARCINOMA

  2021cites this paper
• Combination of EP4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells

  2021cites this paper
• Anticancer Effects of Helminthostachys zeylanica Ethyl acetate Extracts on Human Gastric Cancer Cells through Downregulation of the TNF-α-activated COX-2-cPLA2-PGE2 Pathway

  2021cites this paper
• Aspirin in Hepatocellular Carcinoma

  2021cites this paper
• Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort study

  2020cites this paper
• Challenges in liver cancer and possible treatment approaches.

  2020cites this paper
• Use of cyclooxygenase inhibitor and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nested case‐control study using a nationwide population‐based data

  2020cites this paper
• Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity

  2020cites this paper
• Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma

  2020cites this paper
• In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography.

  2020cites this paper
• Potentiality, Limitations, and Consequences of Different Experimental Models to Improve Photodynamic Therapy for Cancer Treatment in Relation to Antiangiogenic Mechanism

  2020cites this paper
• Herbal and Natural Dietary Products: Upcoming Therapeutic Approach for Prevention and Treatment of Hepatocellular Carcinoma

  2020cites this paper
• Role of the Cyclooxygenase Pathway in the Association of Obstructive Sleep Apnea and Cancer

  2020cites this paper
• Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met.

  2020cites this paper
• Cytotoxicity Evaluation of Dimethoxy and Trimethoxy Indanonic Spiroisoxazolines Against Cancerous Liver Cells

  2020cites this paper
• Mechanism underlying p-coumaric acid alleviation of lipid accumulation in palmitic acid-treated human hepatoma cells.

  2020cites this paper
• Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway

  2019cites this paper
• Altered expression of COX-2 and TNF-α in patients with hepatocellular carcinoma.

  2019cites this paper
• Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.

  2019cites this paper
• RETRACTED: Novel pyran derivatives: Crystal structures and inhibiting human cervical cancer cells evaluation

  2019cites this paper
• Cyclooxygenase‐2 in gastrointestinal malignancies

  2019cites this paper
• Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death

  2018cites this paper
• Celecoxib alleviates AKT/c‐Met‐triggered rapid hepatocarcinogenesis by suppressing a novel COX‐2/AKT/FASN cascade

  2018cites this paper
• Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma

  2018cites this paper
• Oxyphenbutazone promotes cytotoxicity in rats and Hep3B cellsvia suppression of PGE2 and deactivation of Wnt/β-catenin signaling pathway

  2018cites this paper
• Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis

  2018cites this paper
• Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation.

  2017cites this paper
• NF-kappa B activation correlates with disease phenotype in Crohn’s disease

  2017cites this paper
• Evaluation of Cytotoxicity Effects of Chalcone Epoxide Analogues as a Selective COX-II Inhibitor in the Human Liver Carcinoma Cell Line

  2017cites this paper
• Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice

  2017cites this paper
• Antitumor Activities of the Novel Isosteviol Derivative 10C Against Liver Cancer.

  2017cites this paper
• Ionic Liquid-assisted Synthesis of Celexocib Using Tris-(2-hydroxyethyl) Ammonium Acetate as an Efficient and Reusable Catalyst

  2017cites this paper
• Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection

  2017cites this paper
• Non‐invasive detection of bladder cancer via expression‐targeted gene delivery

  2017cites this paper
• Adjuvant Medications That Improve Survival after Locoregional Therapy.

  2017cites this paper
• Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival

  2016cites this paper
• A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment

  2016cites this paper
• Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features

  2016cites this paper
• Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2

  2016cites this paper
• WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals

  2016cites this paper
• High expression of cyclooxygenase-2 in high gradehuman prostate adenocarcinoma

  2015cites this paper
• Expressions of E-cadherin , p 120 ctn , β-catenin and NF-κ B in Ulcerative Colitis *

  2015cites this paper
• Primeros registros de Eupompha imperialis (Wellman, 1912) (Coleoptera Meloidae) en México

  2015cites this paper
• Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles*

  2015cites this paper
• Cyclooxygeanse-2 promotes metastasis in osteosarcoma

  2015cites this paper
• Bisphenol A-induced epithelial to mesenchymal transition is mediated by cyclooxygenase-2 up-regulation in human endometrial carcinoma cells.

  2015cites this paper
• Garlic Oil Suppressed Nitrosodiethylamine-Induced Hepatocarcinoma in Rats by Inhibiting PI3K-AKT-NF-κB Pathway

  2015influential citation
• Polymorphisms in cyclooxygenase-2 gene in endometrial cancer patients

  2015cites this paper
• High Expression of Cyclooxygenase-2 in High Grade Human Prostate Adenocarcinoma (Pengekspresan Tinggi Siklooksigenase-2 dalam Adenokarsinoma Prostat Manusia Gred Tinggi)

  2015cites this paper
• Expressions of E-cadherin, p120ctn, β-catenin and NF-κB in ulcerative colitis

  2015cites this paper
• Prostaglandin E2 Receptor EP1 Transactivates EGFR/MET Receptor Tyrosine Kinases and Enhances Invasiveness in Human Hepatocellular Carcinoma Cells

  2015cites this paper
• Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity

  2015cites this paper
• Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma.

  2015cites this paper
• Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation

  2014cites this paper
• Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

  2014influential citation
• Helicobacter hepaticus Induces an Inflammatory Response in Primary Human Hepatocytes

  2014influential citation
• Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science.

  2014cites this paper
• COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk.

  2014cites this paper
• Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt

  2014cites this paper
• Title Tumor cyclooxygenase-2 levels correlate with tumorinvasiveness in human hepatocellular carcinoma

  2014cites this paper
• Role of Growth Factor Signaling Pathways in Biliary Tract Cancer

  2014cites this paper
• Hepatic Tumors in Childhood

  2014cites this paper
• Combined effect of parthenolide and various anti-cancer drugs or anticancer candidate substances on malignant cells in vitro and in vivo.

  2014cites this paper
• Hepatoprotective Effects of Terminalia chebula Fruit Extract against 2-AAF–Induced Hepatic Damage in Albino Mice: Role of MDR1 and COX-2

  2014cites this paper
• COX-2 expression pattern is related to ovarian cancer differentiation and prognosis, but is not consistent with new model of pathogenesis.

  2014cites this paper
• Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma

  2013cites this paper
• IPA-3 Inhibits the Growth of Liver Cancer Cells By Suppressing PAK1 and NF-κB Activation

  2013cites this paper
• Control of expression of glycosyltransferases involved in O-linked glycosylation in breast cancer

  2013cites this paper
• Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway.

  2013cites this paper
• Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model.

  2013cites this paper
• The story of redundant catenins and their roles in cell-cell adhesion in the liver

  2013cites this paper
• CYCLOOXYGENASE-2 AND HEPATOCELLULAR CARCINOMA: THE PROTEOMICS OF ASSOCIATION

  2013influential citation
• Expression of Rac1, HIF-1α, and VEGF in Gastric Carcinoma: Correlation with Angiogenesis and Prognosis

  2013cites this paper
• Tumor-Related Gene Changes in Immunosuppressive Syrian Hamster Cholangiocarcinoma

  2013cites this paper
• Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant, Anticancer and Anti-HCV Agents

  2013cites this paper
• Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis

  2013cites this paper
• Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.

  2013cites this paper
• Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN

  2013cites this paper
• Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway.

  2013cites this paper
• Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

  2013cites this paper
• Studies on Expression of Apoptosis-Associated Genes and their Relationship with Chemosensitivity in Canine Mammary Tumors

  2013cites this paper